Garheng Kong selected for Aspen Institute's Health Innovators Fellowship

HealthQuest Capital Managing Partner, Dr. Garheng Kong, was selected as one of 21 healthcare industry leaders to participate in the Aspen Insitute's Health Innovators Fellowship. He and the other fellows will participate in a two-year Fellowship designed to strengthen the leadership of innovators across the US health care ecosystem and challenge them to create new approaches to improve the health and well-being of all Americans.

 

Read More
Randy Scott
HQC portfolio company Spirox acquired by Entellus

Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering minimally invasive ENT procedures, today announced that it has entered into a definitive agreement to acquire Spirox, Inc., a privately-held ENT medical technology company that develops, manufactures and markets the LATERA™ Absorbable Nasal Implant, a minimally invasive option for ENTs and facial plastic surgeons to treat nasal airway obstruction. 

Read More
Randy Scott
Trice Medical Closes $19.3 Million Series C Financing

Trice Medical announced today that it closed a $19.3 million Series C financing and will use the proceeds to accelerate and expand the company's U.S. market penetration for mi-eye2™, R&D, sales, marketing and key international regulatory approvals. Smith & Nephew (LSE:SN, NYSE: SNN) has taken a minority stake joining a consortium of current investors including HealthQuest.

Read More
Randy Scott
HealthQuest Joins Syndicate for $42M Investment in Avedro

Avedro, Inc., an ophthalmic pharmaceutical and medical device company and world leader in corneal remodeling, today announced that it secured a combined $42 million in equity and debt financing. The equity financing was led by HealthQuest Capital, with strong support from existing investors OrbiMed Advisors and InterWest Partners. 

Read More
Randy Scott
Blue Cross/Blue Shield Issues Positive Assessment of Castle Bioscience Test

Friendswood, TX – March 29, 2017 – Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment decisions, today announced that Blue Cross Blue Shield Association Evidence Street™ has issued a positive assessment of DecisionDx®-UM, the Company’s gene expression profile (GEP) test to determine prognosis (metastatic potential) in patients diagnosed with uveal melanoma (UM). Evidence Street provides objective information to healthcare and managed care professionals based on clinical and scientific evidence and evaluates whether a technology could improve net health outcomes

Read More
Randy Scott
HealthQuest joins Vesey Street in recapitalization of HealthChannels (ScribeAmerica)

Vesey Street Capital Partners, LLC (VSCP) today announced the completed recapitalization of HealthChannels (parent company of ScribeAmerica), a healthcare services organization with a full suite of solutions that enhances provider productivity, streamlines clerical processes and improves health outcomes. With 13,000 employees across 50 states and three countries, HealthChannels is uniquely positioned to help providers meet increased demands around mission-critical activities ranging from electronic medical records documentation to patient navigation, medical billing and coding. HealthQuest Capital and Heritage Group joined Vesey Street in the financing.

Read More
Randy Scott